The first quarter 2022 report will be available at
https://soft-ox.com/financial-calendar-reports/ and attached.

At 10:00 CET, the management will host a webcast to present the results.
Following the presentation, there will be a Q&A session where written questions
can be submitted to ir@soft-ox.com.

The webcasted presentation will be in Norwegian. To join, please use the link
that is available at https://soft-ox.com/investor-presentations/. 

For further information, please contact:
CEO Geir Almås of SoftOx Solutions AS, or
CFO Kristine Rød of SoftOx Solutions AS
Mail: ir@soft-ox.com
Mobile: (+47) 948 59 599

About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian
medtech/biotech company based in Oslo with the aim of helping to combat major
threats to human health, namely the emergence of antimicrobial resistance (AMR),
biofilm
infections in chronic wounds and the spread of viruses. For more information on
SoftOx, visit www.soft-ox.com

Click here for more information

© Oslo Bors ASA, source Oslo Stock Exchange